NEMAURA MED INC's ticker is NMRD and the CUSIP is 640442208. A total of 22 filers reported holding NEMAURA MED INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,310 | -65.9% | 4,158 | +0.0% | 0.00% | – |
| Q2 2023 | $3,844 | +3.4% | 4,156 | +0.1% | 0.00% | – |
| Q1 2023 | $3,716 | -30.6% | 4,152 | +33.2% | 0.00% | – |
| Q4 2022 | $5,352 | -10.8% | 3,117 | +0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -25.0% | 3,116 | +0.1% | 0.00% | – |
| Q2 2022 | $8,000 | -38.5% | 3,113 | +0.2% | 0.00% | – |
| Q1 2022 | $13,000 | +160.0% | 3,106 | +194.1% | 0.00% | – |
| Q4 2021 | $5,000 | – | 1,056 | +1785.7% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 56 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -94.7% | 56 | -97.7% | 0.00% | – |
| Q1 2021 | $19,000 | -32.1% | 2,400 | -67.7% | 0.00% | – |
| Q4 2020 | $28,000 | +64.7% | 7,420 | +53.8% | 0.00% | – |
| Q3 2020 | $17,000 | -46.9% | 4,826 | +41.7% | 0.00% | – |
| Q2 2020 | $32,000 | – | 3,406 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,842,565 | $580,408 | 0.00% |
| VANGUARD GROUP INC | 126,682 | $39,905 | 0.00% |
| UBS Group AG | 85 | $27 | 0.00% |
| NewEdge Advisors, LLC | 360 | $113 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $158 | 0.00% |
| HAZLETT, BURT & WATSON, INC. | 30 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,158 | $1,310 | 0.00% |
| NORTHERN TRUST CORP | 26,737 | $8,422 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 107,897 | $34,829 | 0.00% |